Matthew Shaw, PhD^1*, Aiyin Liao, PhD^1*, Naeem Khan, PhD^2*, Sylvie D Freeman^3,4, Thomas E. Whittaker, PhD^5*, Adrian J. Thrasher, MBBS, PhD^6*, Martin Pule^7*, Kerry Chester, PhD^8*, Jenny Yeung, PhD^9* and Persis Amrolia, FRCP, FRCPath, PhD^10*

¹UCL Great Ormond Street Institute of Child Health, London, GBR
²Institute of Immunology and Immunotherapy, Birmingham, ENG, GBR
³Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
⁴University of Birmingham, Birmingham, United Kingdom
⁵UCL Great Ormond Street Institute of Child Health, London, United Kingdom
⁶UCL Great Ormond St Institute of Child Health, London, United Kingdom
⁷University College London, London, GBR
⁸UCL Cancer Institute, London, GBR
⁹UCL Great Ormond Street Institute of Child Health, London, ENG, United Kingdom
¹⁰Great Ormond Street Children’s Hospital, London, United Kingdom

Elijah P Darnell, MD^1,2,3, Hana N Takei^3*, Mark B Leick, MD^1,3*, Filippo Birocchi, PhD^3*, Amanda A Bouffard^3*, Trisha R Berger, PhD^3* and Marcela V Maus, MD, PhD^1,3

¹Harvard Medical School, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Cellular Immunotherapy Program, Mass General Cancer Center, Massachusetts General Hospital, Boston, MA

Alexandra E. Rojek, MD¹, Lishi Xie, PhD^2*, Alan J. Cooper^3*, Xiufen Chen, PhD^1*, Peter A. Riedell, MD^1,2, Michael R Bishop, MD^1,2 and Justin Kline, MD^1,4

¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
³Yale School of Medicine, New Haven, CT
⁴University of Chicago, Chicago, IL

Charlotte Junkuhn^1,2,3*, Phillip Schiele^3,4*, David Busch^4*, Julia Polansky-Biskup^5,6*, Annette Künkele-Langer^1,7*, Benedikt Obermayer^8*, Lars Bullinger^9,10,11,12, Marco Frentsch^4,6* and Il-Kang Na^{1,4,6,13,14,15,16,17*}

¹BSIO Berlin School of Integrative Oncology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
²Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Berlin, AL, Germany
³Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany
⁴Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Berlin, Germany
⁵Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany
⁶Berlin Institute of Health at Charité – Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Therapy-Induced Remodeling in Immuno-Oncology, Berlin, Germany
⁷Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany
⁸Core Unit Bioinformatics - CUBI, Berlin Institute of Health, Berlin, DEU
⁹Department of Internal Medicine III, University of Ulm, Germany, Berlin, DEU
¹⁰German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
¹¹Department of Hematology, Oncology, Tumor Immunology, Charité University Medicine, Berlin, Germany
¹²University of Ulm, Berlin, Germany
¹³Medical Department of Hematology, Oncology and Tumor Immunology, Molekulares Krebsforschungszentrum (MKFZ), Charité - Universitätsmedizin, Berlin, Germany
¹⁴Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, ECRC Experimental and Clinical Research Center, Berlin, Germany
¹⁵German Cancer Consortium (DKTK), Berlin, Germany
¹⁶Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany
¹⁷Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany

Salvatore Fiorenza, MBBS, PhD, BSc, FRACP, FRCPA, MPH¹, Yue Cao, PhD^2*, Ye Zheng, PhD^3*, Janaki Purushe^4*, Tamara Bock^5*, Erik L Kimble, MD⁶, Derek Janssens, PhD^7*, Delaney Kirchmeier, BS^6*, Alexandre V. Hirayama, MD⁸, Jordan Gauthier, MD, MSc⁶, David G. Maloney, MD, PhD⁹, Stanley R. Riddell, MD¹⁰, Akira Nguyen-Shaw, PhD^11*, Steven Henikoff, PhD^12*, Jean Yang^13* and Cameron J. Turtle, MBBS, PhD^14*

¹Faculty of Medicine and Health, University of Sydney, Balwyn North, VIC, Australia
²Sydney Precision Data Science Centre, University of Sydney, Sydney, Australia
³Bioinformatics and Computational Biology Department, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Fred Hutchinson, Seattle, WA
⁵Faculty of Medicine and Health, University of Sydney, Camperdown, Australia
⁶Fred Hutchinson Cancer Center, Seattle, WA
⁷Basic Sciences Division, Van Andel Ins, Seattle, WA
⁸Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁹Fred Hutch Cancer Center, University of Washington, Seattle, WA
¹⁰Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
¹¹Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia
¹²Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
¹³Sydney Precision Data Science Centre, University of Sydney, Camperdown, NSW, Australia
¹⁴University of Sydney, Sydney, NSW, Australia

Ayaka Goto^1*, Midori Ishii^1*, Shintaro Kinoshita^1*, Yoshiki Furukawa^1*, Norihide Izumi^1*, Jun Ando^1,2*, Hiromitsu Nakauchi^3,4* and Miki Ando¹

¹Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
²Division of Cell Therapy & Blood Transfusion Medicine, Juntendo University School of Medicine, Tokyo, Japan
³Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford
⁴Stem Cell Therapy Laboratory, Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

Alexander P. Boardman, MD^1,2*, Adhithi Rajagopalan, PhD^3*, Sophia Chen, MD^3*, Brandon Ng, PhD^3*, Jacob Fischman^3*, Alyssa Massa^3*, Harold K Elias, MD⁴, Dylan Manuele^4*, Mohamed I. Atmane^5*, Ileana Miranda, DVM, MSc, DACVP^5*, Scott E. James, MD, PhD^6,7 and Marcel R.M. van den Brink, MD, PhD^6,8,9

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY
³Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Center of Comparative Medicine & Pathology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Immunology, Sloan Kettering Institute, New York, NY
⁷Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁹Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY

Nira Krasnow, MD^1,2,3*, Katie Maurer, MD, PhD^2,3,4, Catherine Song^4*, Timothy Blewett^5*, Kan Xiong^5*, Andela Crnjac^6*, Lily Gao^4*, Justin Rhoades^5*, Reid W. Merryman, MD^2,7,8, Satyen Gohil, MD PhD^9*, Caitlyn Duffy^10*, Liliana Guerrero^2*, Mikaela M. McDonough^11*, Robert A. Redd, MS^12*, Heather Jacene^13*, Jamie Dela Cruz^14*, Justin Budka^15*, Mike Mattie, PhD^16*, Brodie Miles, PhD^17*, Donna S. Neuberg, ScD¹², Philippe Armand, MD, PhD², Catherine J. Wu, MD^2,3,4*, Viktor Adalsteinsson^5* and Caron A. Jacobson, MD, MMSc²

¹Department of Medicine, University of California, San Francisco, San Francisco
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Harvard Medical School, Boston, MA
⁴Broad Institute of MIT and Harvard, Cambridge, MA
⁵Broad Institute, Boston, MA
⁶Broad Institute, BOSTON, MA
⁷Department of Medical Oncology, Brigham and Women's Hospital, Boston, MA
⁸Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁰Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
¹¹Dana-Farber Cancer Institute, Boston, MA
¹²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
¹³Department of Imaging, Dana-Farber Cancer Institute, Boston, MA
¹⁴Dana Farber Cancer Institute, Boston, MA
¹⁵Kite, A Gilead Company, Santa Monica, CA
¹⁶Kite Pharma, a Gilead company, Santa Monica, CA
¹⁷Kite Pharma, a Gilead Company, Santa Monica, CA

Tiffany Que, MS^1,2,3*, Lucas SP Rudden, PhD^3,4*, André Sobczyk, PhD^1,3*, Patrick Barth, PhD^3,4* and Caroline Arber, MD^2,3,5

¹Department of oncology UNIL-CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
²University of Lausanne, Lausanne, Switzerland
³Ludwig Institute for Cancer Research, Lausanne, Switzerland
⁴Institute of Bioengineering, Ecole Polytechnique Fédérale Lausanne, Lausanne, Switzerland
⁵Department of oncology UNIL-CHUV, Lausanne University Hospital, Epalinges, Vaud, Switzerland

Yuan Xia, MD^1*, Xuxing Shen^2*, Min Shi^3*, Na Shen^3*, Yu Zhu, MD^4*, Lei Fan^5*, Jianyong Li, MD⁶ and Lijuan Chen^7*

¹Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu Province, China
²Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
³The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁴Department of Hematology, Jiangsu Provincial People's Hospital, Nanjing, China
⁵Lymphoma Center, Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⁶First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁷Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Danny Luan, MD, MPH¹, Susan DeWolf, MD², Teng Fei, PhD^3*, Sandeep S. Raj, MD⁴, Gunjan L. Shah, MD⁵, Caleb Lareau, PhD^6*, Mohammad Alhomoud, MD⁷, Gilles Salles, MD, PhD⁸, Alfredo Rivas-Delgado, MD, PhD⁹, Kai Rejeski, MD¹⁰, Jae H. Park, MD¹¹, Efrat Luttwak, MD⁹, Alejandro Luna, MD, PhD^12*, Magdalena Corona, MD, PhD^4*, Evangelos Ntrivalas, MD, PhD^13*, Giulio Cassanello, MD^14*, Marina Gomez-Llobell, MD^4*, Allison Parascondola, MPH^14*, Michael Scordo, MD¹⁵, Katharine C. Hsu, MD, PhD⁶, Maria Lia Palomba, MD⁹, Miguel Angel Perales, MD¹⁶ and Roni Shouval, MD, PhD⁴

¹Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY
²Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York
⁸Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Department of Medicine III, LMU University Hospital, Munich, Germany
¹¹Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Unidad de trasplante y terapia celular, Hospital Universitario Ramon y Cajal, Madrid, Spain
¹³Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York
¹⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁵Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY
¹⁶Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Idit Sagiv Barfi, PhD¹, Eric Liao^1*, Michael S Mannon^2*, Boi Quach^2*, Lingyan Wang^2*, Samantha Koo-McCoy^2*, Michael C Yi^2*, James S Byers III^2*, Nhung Nguyen^2*, Trevor M Bentley^2*, Savannah Yung^3*, Yu Huang^2*, Michael T Bethune^2*, Matthew Siegel^2* and Michael O Ports^2*

¹Cargo Therapeutics, San Carlos, CA
²Cargo Therapeutics, San Carlos
³Cargo Therapeutics, San Calos

Nikhil Chilakapati^1*, Bonell Patino-Escobar, MD^1*, Jonathan deMontagnac^1,2*, Haley Johnson^3*, Emilio Ramos, MD, PhD⁴, Paul Phojanakong, BA^5*, Fernando Salangsang^5*, Veronica Steri, PhD^5*, William J Karlon, MD, PhD^1* and Arun P Wiita, MD, PhD³

¹Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
²College of the Holy Cross, Worcester, MA
³Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
⁴Department of Laboratory Medicine, University of California San Francisco, ALAMEDA, CA
⁵Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA

Amrik S Kang^1,2*, Haley Johnson^3*, Nabeel Razi^4*, Nicole Lei^4*, Aaron C. Logan, MD, PhD⁴, Benjamin J Huang, MD⁵ and Arun P Wiita, MD, PhD³

¹Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
²Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA
³Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
⁴Department of Medicine, Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA
⁵Department of Pediatrics, University of California, San Francisco, San Francisco, CA

Jincai Zhou^1*, Xinran Luo^2*, Bixia Lei^1*, Kai Wu^2*, Feifei Shi^2*, Yuting Zhang^1*, Jingyi Yu^2*, Hong Ma, MD³, Zhe (Joy) Zhou^4* and Xiaowen He^1*

¹R & D, OriCell Therapeutics Co.,Ltd, Shanghai, China
²R & D, Shanghai Yihe Shiji Pharmaceutical Co., Ltd., Shanghai, China
³ORICELL THERAPEUTICS INC, Dover
⁴Shanghai Yihe Shiji Pharmaceutical Co., Ltd., Shanghai, China

Mimi Chen, PhD^1*, Wenbin Mo, MMSc^1*, Gennaro Clando^2*, Yuanyuan Tian, PhD^1*, Ciril Abraham, BS^1,3*, Qingrong Huang^1,4*, Ying WANG^1*, Morgan Chaunzwa^1*, Yan Zhou, MS^5*, Andrew Ip, MD, MSc⁶, Andre Goy, MD, MS⁶, Jaroslav Jelinek^2*, Jozef Madzo^2*, Jean-Pierre Issa^2* and Yi Zhang, MD, PhD¹

¹Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ
²Coriell Institute for Medical Research, Camden, NJ
³Fels Institute and Department of Cancer Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA
⁴Clinical Immunology Core, Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ
⁵Fox Chase Cancer Center, Temple University, Philadelphia
⁶Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ

Anand S Bhagwat, MD, PhD^1,2, Maksim Shestov^3*, Olga Shestova, PhD^3* and Saar Gill, MD, PhD^3,4

¹Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
²Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
³Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁴School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA

Guo-Ling Wang^1,2*, Ting Wang^1,2*, Jing-Li Han^1*, Li-Xin Wu^1,2*, Xuan-Zhong Chen^1,2*, Zhuo-Yu An^1*, Chen-Cong Wang^1*, Peng Zhao^1*, Lu-Lu Wang^1*, Mengtong Zang, MS^1*, Wei Zheng^3*, Hai-Xia Fu^1*, Jia Feng^4*, Hong-Yu Zhang^4* and Xiaohui Zhang¹

¹Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
²Department of Hematology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China
³Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen, China
⁴Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China

Afroditi Katsarou^*, Georgios Kladis^*, Alexandros Nianias^*, Jiaxian Wang^*, Thomas Baardemans^*, Ruud Ruiter^*, Marie José Kersten^*, Sonja Zweegman, MD, PhD, Tuna Mutis, MD PhD^*, Richard Groen^* and Maria Themeli, MD, PhD^*

Department of Hematology, Amsterdam UMC-location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands

Ran Jing^1*, Marcelo Falchetti, Ph.D.^2*, Tianxiao Han^3*, Mohamad Najia, PhD^4*, Luca Hensch^5*, Eleanor Meader, PhD^2*, Martin Kononov^2*, Stephanie Wang^2*, Caroline Kubaczka, PhD^6*, Edroaldo Lummertz Da Rocha, PhD^7*, Robert Grant Rowe, MD, PhD⁸, Thorsten M. Schlaeger, PhD^1*, Marcela Maus, MD⁹, Trista E. North, PhD¹⁰, Leonard I. Zon, MD^11,12 and George Q. Daley, MD, PhD¹

¹Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA
²Stem Cell Program, Boston Children's Hospital and Harvard Medical School, Boston
³Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA
⁴Harvard Medical School/Boston Children's Hospital, Boston, MA
⁵Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School; Harvard University, Boston, MA
⁶Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute; Harvard Medical School; Harvard University, Boston, MA
⁷Federal University of Santa Catarina, Florianopolis, BRA
⁸Department of Hematology/Oncology, Harvard Medical School/Boston Children's Hospital, Boston, MA
⁹Harvard Medical School, Lexington, MA
¹⁰Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA
¹¹Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital; Howard Hughes Medical Institute; Harvard Medical School; Harvard Stem Cell Institute; Harvard University, Boston, MA
¹²Howard Hughes Medical Institute, Boston, MA

Carolina Martinez-Laperche, PhD^1,2*, Gonzalo Del Campo-Balguerias^3*, Ismael De La Iglesia San Sebastián^2,4*, Juan Carlos Triviño^5*, Francisco Diaz Crespo^6*, Rebeca Bailen^2,4*, Raquel Fernandez-Gonzalez^7*, Sara Fernandez-de Córdoba^8*, Ana Jiménez Ubieto^9*, Alejandro Martín-Muñoz^9*, Paula Fernández Caldas-González^10*, Ignacio Gómez-Centurión, MD^2,4*, Mi Kwon, MD, PhD^11,12, Javier Anguita^2,4*, Ramon García-Sanz, MD, PhD¹, Ismael Buño^13* and Mariana Bastos-Oreiro^4,14*

¹Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
²General University Hospital Gregorio Marañón, Madrid, Spain
³Hospital Universitario Clínico mADRID, Madrid, Spain
⁴Health Research Institute Gregorio Marañón, Madrid, Spain
⁵Sistemas Genómicos, Valencia, Spain
⁶Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁷Instituto de Investigación sanitaria Gregorio Marañón, Madrid, Spain
⁸Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
⁹Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain
¹⁰Hematology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
¹¹Department of Hematology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
¹²Institute of Health Research Gregorio Marañon, Madrid, Spain
¹³Hospital General Universitario Gregorio MarañóN. Instituto De Inve, Madrid, Ma, ESP
¹⁴Hematology Department, General University Hospital Gregorio Marañón, Madrid, Spain

Siddarth Chandrasekaran^1*, Vignesh Janardhanam^2*, Ian Cardle^2*, Justin Yoo^3*, Yue Zhang-Wong^2*, Julia Bershadsky^4*, Elisa Martinez^4*, April Marple^4*, Laxsha Thaya^4*, Charlie Liu^4*, Dhanya Vijayan^4*, Leanne Jamieson^4*, Lifu Sheng^4*, Elizabeth Csaszar^4*, Emily Titus^4* and Chris Bond²

¹Notch Therapeutics, Seattle, WA
²Notch Therapeutics, Seattle
³Notch Therapeutics, Everett, WA
⁴Notch Therapeutics, Toronto, Canada

Alissa H. Brandes^1*, Angela Soo Min Koo, BSc^1*, Anai Perez^1*, Kathryn Michels, PhD^1*, Travis Friesen, PhD^1*, Alyssa Sheih, PhD^1*, Don Parilla^2*, Susana Hernandez^1*, Nolan Ericson, BSc^1*, Sarah Dickerson, PhD^2*, Mason Muhonen^2*, Jessica Freeman^2*, Sarah Gould^2*, Alessandra Maria Sullivan, PhD^2*, Jeffrey Teoh, PhD^1*, Byoung Y. Ryu, PhD¹, Andrew M. Scharenberg, MD^1* and Ryan P. Larson, PhD^1*

¹Umoja Biopharma, Seattle, WA
²Umoja Biopharma, seattle, WA

Shirisha Amatya, MS^1*, Jesse Green, PhD^1*, Chi-Shuen Chu, PhD^2*, Adam Hilterbrand, PhD^2*, Reuben Burch^1*, Chris Baldeviano, PhD^3*, Edward Rebar, PhD^4*, Terry J Fry, MD¹, Albert Ruzo, PhD^1*, Kutlu G Elpek, PhD^5* and Kyle Trudeau, PhD^5*

¹Sana Biotechnology, Seattle, WA
²Sana Biotechnology, Seattle
³Sana Biotechnology, Cambridge
⁴Sana Biotechnology, Richmond, CA
⁵Sana Biotechnology, Cambridge, MA

Conor Kelly, MSc^1*, Wenjun Zhu, MD, PhD^2*, Keyvan Keyvanfar^3*, Pradeep Dagur, PhD^4* and Stefan Cordes, MD, PhD⁵

¹Georgetown University School of Medicine, Washington, DC
²Thoracic and GI Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD
³National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda, MD
⁴Flow Cytometry Core, National Heart Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD
⁵Translational Stem Cell Biology Branch, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Nat Murren, B.S.^1*, Isaac King^2*, Lauren Mahoney^1*, Paresh Vishwasrao^3*, Jessica Kain, MS¹, Morgan Antti^1*, Luke Kalcheim^1* and Rebecca M Richards, MD, PhD^4,5,6

¹University of Wisconsin-Madison, Madison, WI
²University of Wisconsin Madison, Madison, WI
³Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, University of Wisconsin-Madison, Madison
⁴University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
⁵Wisconsin Blood Cancer Research Institute, University of Wisconsin-Madison, Madison, WI
⁶Department of Pediatrics, University of Wisconsin-Madison, MADISON, WI

Danielle C. Kirkey, MD^1,2, Grace Hawkins^1*, Melia Blankenfeld, BS^1*, Isabel Lira, BS^1*, Nika Panahi, BS^1*, Margaret G Hines^3*, Seungmin Shin^3*, Tiffany Hylkema, BS^1*, Cyd McKay^1*, Christina Root^1*, Logan K. Wallace, MSc^1*, Jack H. Peplinski, MSc^1*, Rhonda E. Ries, MA^1*, Concetta Quintarelli, PhD^4*, Franco Locatelli, MD⁴, Wei Li, PhD^3* and Soheil Meshinchi, MD, PhD¹

¹Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
²Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA
³Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA
⁴IRCCS Bambino Gesù Children's Hospital, Rome, Italy

Julia Han Noll^1,2,3*, Humza Hemani^4*, Jiang Yuan Li, PhD^4*, Kevin R. Amses, PhD^3,5,6*, Bruce Levine, PhD^2,3,7, Carl H. June, MD^2,3,8,9, Nan-Ping Weng, PhD^4* and Joseph A. Fraietta, PhD^3,5,10*

¹Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
²Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
³Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁴National Institute On Aging, National Institutes of Health, Baltimore, MD
⁵Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁶Department of Microbiology, University of Pennsylvania, Philadelphia, PA
⁷Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁸Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
⁹Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
¹⁰Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Yinqiang Zhang^1,2*, Wu Zhuolin^1,2*, Wenjing Luo^1,2*, Chenggong Li^1,2* and Heng Mei^1,2*

¹Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China

David M Foureau¹, Fei Guo, PhD^1*, Erik Broemsen, PhD^1*, Tahj Jones^1*, Anna Ivanina-Foureau, PhD^1*, Ryan Jacobs², Bei Hu, MD², Tamara K Moyo, MD^2*, Yifan Pang, MD², Steven I. Park, MD², Lawrence J. Druhan, PhD³, Ariel Bell, MPH^3* and Nilanjan Ghosh, MD, PhD²

¹Levine Cancer Institute, Atrium Health, Charlotte, NC
²Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
³Hematology Oncology Translational Research Laboratory, Atrium Health Levine Cancer Institute, Charlotte, NC